Диссертация (1151316), страница 51
Текст из файла (страница 51)
Ye,A.C. Scallet, R.J. Kascsak, R.I. Carp // Brain research. – 1998. – V. 2(809). –Р. 277–287.370. Law, A. Say NO to Alzheimer’s disease: the putative links between nitric oxide,the dementia of the Alzheimer’s type / A. Law, S. Gauthier, R. Quirion // Brainresearch. Brain research reviews. – 2001. – V. 1(35).
– P. 73–96.371. He, F. Glial cells more than support cells? / F. He, Y.E. Sun // Theinternational journal of biochemistry and cell biology. – 2007. – V. 4(39). –P. 661–665.316372. Petzold, A. Neuronal and glial cerebrospinal fluid protein biomarkers areelevated after West Nile virus infection / A. Petzold, M. Groves, A.A Leis et.al.
// Muscle and nerve. – 2010. – V. 1(41). – P. 42–49.373. Olabarria, M. Concomitant astroglial atrophy and astrogliosis in a tripletransgenic animal model of Alzheimer's disease / M. Olabarria, H.N. Noristani,A. Verkhratsky, J.J. Rodríguez // Glia. – 2010. – V. 7(58). – P.
831–838.374. De Armond, S.J. The application of glial fibrillary acidic (GFA) proteinimmunohistochemistry in neurooncology. A progress report / S.J. De Armond,L.F. Eng, L.J. Rubinstein // Pathology, research and practice. – 1980. – V. 4(168). –Р. 374–394.375. Березин, В.А. Нейроспецифические белки в диагностике опухолейголовного мозга человека / В.А. Березин, Е.Н.
Жмарева, С.А. Ромоданов и др.// Вопросы онкологии. – 1985. – № 12(31). – С. 7–17.376. Dahl, D. Glial fibrillary acidic (GFA) protein in vertebrates: Immunofluorescence and immunoblot- ting study with monoclonal and polyclonal antibodies /D. Dahl, C.J. Crosby; A. Sethi, A. Bignami // The journal of comparativeneurology. – 1985. – V. 239. – Р.
75–88.377. Morrison, C.D. Immunohistochemistry in the diagnosis of neoplasms of thecentral nervous system / C.D. Morrison, R.A. Prayson // Seminars in diagnosticpathology. – 2000. – V. 3(17). – Р. 204–215.378. Moore, B.W. Chromatographic and electrophoretic fractionation of solubleprotein of brain and liver / B.W. Moore, D. McGregor // J Biol Chem – 1965. –V. 4(240). – P. 1642–1653.379.
Kalman, M. Comparative study on astroglial markers, GFAP, glutaminesynthetase and S-100 in skate brain / M. Kalman, C. Ari // Ann Anat Suppl. –2001. – V. 183. – Р. 104.380. Старостина, М.В. Нейроспецифический белок S-100 / М.В. Старостина,С.М. Свиридов // Усп. Совр. Биологии. – 1977. – № 2(84). – С. 176–188.3172+381. Starostina, M.V. Studies on interaction of Ca ions with some fractions of theneurospecific S-100 protein / M.V. Starostina, T.K.
Matup, S.M. Sviridov //J Neurochem. – 1981. – V. 1(36). – P. 1904–1915.382. Stefansson, K. Distribution of S-100 protein outside the central nervous system /K. Stefansson, R.L. Wollmann, B.W. Moore // Brain Res. – 1982. – V. 2(234). –P. 309–317.383. Baudier, J. Zinc-dependent affinity chromatography of the S-100β protein onphenyl-sepharose / J. Baudier, C.
Holtzscherer, P. Gerard // FEBS Lett. – 1982. –V. 2(148). – P. 231–234.384. Baudier, J. Bovine brain S-100 proteins: separation and characterization of newS-100 protein species / J. Baudier, P. Mandel, P. Gerard // J Neurochem. – 1983. –V 1(40) – P. 145–152.385. Alema, S. Calcium and brain proteins / S. Alema // Metal ions in biologicalsystems. – 1987. V. 17. – P. 275–317.386.
Isobe, T. S-100α protein is present in neuronsof the central and peripheral nervoussystem / T. Isobe, K. Takahashi, T. Okuyama // Ibid. – 1984. – V. 5(43). –P. 1494–1496.387. Many, R.S. Isolation and spectral studies on the calcium binding properties ofbovine brain S-100 protein / R.S. Many, C.M. Kay // Biochem. – 1983. – V. 16(22).– P. 3902–3907.388. Капралов, А.А. Влияние белка S-100 на фосфорилирование ядерныхбелков мозга крысы: участие ионов кальция / А.А. Капралов, Д.И. Балков,В.И.
Тюленев, Я.В. Белик // Нейрохимия. – 1985. – № 1(4). – С. 23–29 .389. Капралов, А.А. Об участии белка S-100 в фосфорилировании белковнуклеоплазмы мозга и его наличии в рибонуклеопротеидных частицах /А.А. Капралов, В.И. Тюленев, Я.В. Белик // Нейрохимия. – 1988. – № 3(7).– С. 382–388.390. Kubista, H. Hermann A. S100 calcium binding protein affects neuronalelectrical discharge activity by modulation of potassium currents / H. Kubista,R. Donato, A. Hermann // Neurosci. – 1999. – V.
2(90). – P. 493–508.318391. Garbuglia, M. The calcium-modulated proteins, S100A1 and S100B, aspotential regulators of the dynamics of type III intermediate filaments /M. Garbuglia, M. Verzini, G. Sorci et. al. // Braz. J. Med. Biol. Res. – 1999. –V. 10(32). – P. 1177–1185.392. Baydas, G. Increase of glial fibrillary acidic protein and S-100B in hippocampusand cortex of diabetic rats: effects of vitamin E / G. Baydas, V.
S. Nedzvetskii,M. Tuzcu, et. al. // Eur J Pharmacol. – 2003. – V. 1–3(462). –Р. 67–71.393. Vos, P.E. Glial and neuronal proteins in serum predict outcome after severetraumatic brain injury / P.E. Vos, K.J. Lamers, J.C. Hendriks et. al. //Neurology – 2004. – V. 8(62). – Р. 1303–1310.394. Hertz, L. Signaling and gene expression in the neuron-glia unit during brainfunction and dysfunction: Holger Hyden in memoriam / L. Hertz, E. Hansson,L. Ronnback // Neurochem Int. – 2001.
– V. 3(39). – P. 227–252.395. Туровский, В.С. Нейроспецифический белок S-100 в синаптосомах корыголовного мозга крыс / В.С. Туровский, В.С. Репин, В.В. Надточий // Бюл.Эксп. Биологии и медицины. – 1976. – № 2(81). – С. 164–165.396. Donato, R. Soluble and membrane-bound S-100 protein in rat cerebral cortexsynaprosomes during postnatal development / R. Donato // Brain Res. – 1976. –V. 3(108). – P.
649–655.397. Ghanour, M.S. A biochemical and immunohistological study of S-100 protein indeveloping ra cerebellum / M.S. Ghanour, G. Labourdette, G. Vincendon,G.A. Gombos // Develop Neurosci. – 1981. – V. 2(4). – P. 98–109.398. Martinez, G. GFAP, S-100 and vimentin proteins in rat after cerebral postischemic reperfusion / G. Martinez, M.L. Carnazza, C.
Di Giacomo et. al. // IntJ Dev Neurosci. – 1998. – V. 6(16). – P. 519–526.399. Pelinka, L.E. GFAP versus S100B in serum after traumatic brain injury:relationship to brain damage and outcome / L.E. Pelinka, A. Kroepfl,M. Leixnering et. al. // J Neurotrauma. –2004. – V. 11(21). – Р. 1553–1561.319400. Hayakata, T.
Changes in CSF S100B and cytokine concentrations in earlyphase severe traumatic brain injury / T. Hayakata, T. Shiozaki, O. Tasaki et. al.// Shock. – 2004. – V. 2(22). – Р. 102–107.401. Goncalves, C.A. Biological and methodological features of the measurementof S100B, a putative marker of brain injury / C.A. Goncalves, M.C. Leite,P. Nardin // Clin Biochem. – 2008.
– V. 41. – Р. 755–763.402. Van Eldik, L.J. The Janus face of glial-derived S100B: beneficial anddetrimental functions in the brain / L.J. Van Eldik, M.S. Wainwright // RestorNeurol Neurosci. – 2003. – V. 3–4(21). – Р. 97–108.403. Rothermundt, M. S100B in brain damage and neurodegeneration /M. Rothermundt, M. Peters, J.H. Prehn, V. Arolt // Microsc Res Tech. – 2003. –V. 6(60). – Р. 614–632.404. Wunderlich, M.T. Release of neurobiochemical markers of brain damage isrelated to the neurovascular status on admission and the site of arterialocclusion in acute ischemic stroke / M.T.
Wunderlich, C.W. Wallesch,M. Goertler // J Neurol Sci. – 2004. – V. 1(227). – Р. 49–53.405. Hovsepyan, M.R. Astrocytic and neuronal biochemical markers in the sera ofsubjects with diabetes mellitus / M.R. Hovsepyan, M.J. Haas, A.S. Boyajyan et.al. // Neurosci Lett.
– 2004. – V. 3(369). – Р. 224–227.406. Kogel, D. S100B potently activates p65/c-Rel transcriptional complexes inhippocampal neurons: Clinical implications for the role of S100B in excitotoxicbrain injury / D. Kogel, M. Peters, H.G. Konig et. al. // Neuroscience. – 2004. –V. 4(127). – Р. 913–920.407. De Boussard, C.N. S100 and cognitive impairment after mild traumatic braininjury / C.N. de Boussard, A. Lundin, D. Karlstedt et.
al. // J Rehabil Med. –2005. – V. 1(37). – Р. 53–57.408. Stapert, S. S-100B concentration is not related to neurocognitive performancein the first month after mild traumatic brain injury / S. Stapert , J. de Kruijk,P. Houx et. al. // Eur Neurol. –2005. – V. 1(53). – Р. 22–26.320409. Alatas, O.D. Neuron-Specific Enolase, S100 Calcium-Binding Protein B,and Heat Shock Protein 70 Levels in Patients With Intracranial Hemorrhage /O.D. Alatas, M. Gurger, M.
Atescelik et. al // Medicine. – 2015. – V. 4(94).P. 207–210.410. Kanner, A.A. Serum S100beta: a noninvasive marker of blood-brain barrierfunction and brain lesions / A.A. Kanner, N. Marchi, V. Fazio et. al. // Cancer.–2003. – V. 11(97). – Р. 2806–2813.411. Liu, W. S100β in heavy metal-related child attention-deficit hyperactivitydisorder in an informal e-waste recycling area / W. Liu, X. Huo, D. Liu et.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
